The system is designed to be implanted with Blue Belt’s robotic-assisted technology — the Navio system. STRIDE is available for treatment of both medial and lateral unicompartmental knee replacement.
The system received FDA clearance in June 2014 and has been commercially available in the United States since October.
Blue Belt technologies saw significant growth in 2014 and reported a strong commercial performance. It sold 33 Navio Surgical Systems worldwide and there were more than 900 partial knee replacements performed with five implant partners using the STRIDE Unicondylar Knee System.
More articles on devices:
OrthAlign grew 46% in 2014 — 5 things to know
Medtronic-Covidien deal final — but how will it change the industry? 7 thoughts
OSU Wexner Medical Center physicians 1st to implant plastic device for cartilage damage
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
